
Australian immunologist fascinated by the immune processes underlying cancer and allergy | @CCB_Research | Passe & Williams Foundation Fellow
Adelaide, South Australia
Joined August 2019
- Tweets117
- Following300
- Followers267
- Likes659
Pinned Tweet
Delighted to have the work from my post doc with @LabListon out in @JExpMed today! We show how the cellular context in which IL2 is expressed leads to vastly different outcomes:
https://teapawt.net/t.co/isnFdoNczL
Carly Whyte retweeted
Thrilled to share new work led by @JieYang437 in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre rdcu.be/eci1U
We are excited to recruit a PhD student for 2025 @CCB_Research in Adelaide to tackle immune dysfunction in head and neck cancer.
Please share and apply: unisa.edu.au/research/degree…
Carly Whyte retweeted
Following several kind requests, here is a high-level summary of our pre-print in @biorxivpreprint (doi: doi.org/10.1101/2024.10.03.6…):
STAMP: Single-Cell Transcriptomics Analysis and Multimodal Profiling through Imaging
STAMP is a scalable, cost-efficient method for single-cell transcriptomics and multimodal profiling through imaging. It bypasses sequencing, significantly reducing costs while enhancing throughput.
#SingleCellRNA #SpatialOmics #STAMP
The motivation for this paper comes from the limitations of current scRNA-seq methods, which are costly, inefficient, and struggle to capture low- and high-abundance transcripts. Challenges like droplet instability, cell damage, limited cell capture, cross-contamination, inefficient indexing, and high sequencing costs affect ultra-low and ultra-high cell profiling, hindering accurate analysis of complex cell populations. #Limitations #DropletMicrofluidics
STAMP addresses these issues with a scalable, cost-effective, sequencing(costs)-free approach that works efficiently across ultra-low to ultra-high cell numbers, while preserving cellular morphology and enabling multimodal profiling. #SpatialOmics #UltraLow #UltraHigh
STAMP uses an imaging-based approach to perform high-throughput RNA and protein profiling by stamping cells onto slides compatible with CosMx and Xenium platforms, allowing multimodal profiling in a single run.
#Proteomics
STAMP supports single-modal (RNA/protein) and multimodal (RNA + protein) profiling, enhancing experimental flexibility and scalability. This versatility is essential for large-scale atlases and mixed-sample experiments.
#SingleCellAtlas #MultiSampleProfiling
STAMP scales easily: from less than 100 to millions of cells. It overcomes limitations in droplet-based systems, where throughput is often constrained by sequencing costs.
#HighThroughput
STAMP handles diverse sample types: PBMCs, dissociated tumors, nuclei, and stem cells. It also excels with fragile or archived tissues, where traditional methods often fail to yield high-quality data.
#ArchivedSamples
STAMP eliminates sequencing costs, making large-scale single-cell analysis accessible to more labs. #CostEfficiency
Here’s a cost comparison between GEM-X and STAMP-X for RNA profiling:
GEM-X RNA (20k cells): $0.0764/cell
1M cells = $76,400 (cost/cell = $0.0764)
2M cells = $152.800 (cost/cell = $0.0764)
3M cells = $229,200 (cost/cell = $0.0764)
STAMP-X RNA (1M cells): $0.0075/cell
1M cells = $7,500 (cost/cell = $0.0075)
2M cells = $7,500 (cost/cell = $0.00375)
3M cells = $7,500 (cost/cell = $0.0025)
In STAMP cells remain intact after imaging, enabling further downstream applications like histological validation or additional molecular assays, adding value to each sample.
#NonDestructiveAnalysis
We tested STAMP’s sensitivity by identifying, ultra-rare, circulating tumor cells (CTCs) spiked into PBMCs at 1:100,000. Such sensitivity is essential for clinical diagnostics, particularly in rare cell detection.
#CTCs #CancerDiagnostics
In a high-throughput immuno-phenotyping experiment, STAMP profiled 1.7M PBMCs, capturing a median of 83 transcripts and 49 genes per cell. This resulted in high-resolution immune profiling.
#Immunology #HighThroughputProfiling
31 immune cell states were mapped in PBMCs, capturing rare subpopulations (Th1/Th2/Th17 and NK subtypes). Detailed immune phenotyping is critical for understanding immune diversity in health and disease.
#ImmuneMapping
Whole cells vs. nuclei: STAMP's ability to profile both whole cells and nuclei is crucial for samples with low RNA content (e.g., archived tissues), increasing the platform’s applicability.
#NucleiProfiling #SingleCellOmics
STAMP integrates RNA and protein profiling. In cancer cell line profiling, RNA and protein data showed strong correlations, confirming the platform’s robustness in multimodal data collection.
#MultimodalProfiling
STAMP’s multimodal profiling produced high-resolution immune maps, combining RNA and protein data. This approach is essential for dissecting complex immune states and understanding functional responses.
STAMP excels in low-input samples. We demonstrated its ability to accurately profile as few as 100 cells, which is critical for studying rare populations in small samples.
#LowInput #RareCell
In a BMP4-driven stem cell differentiation model, STAMP captured dynamic changes from pluripotency to mesoderm and endoderm progenitors over multiple timepoints, tracking lineage differentiation.
#StemCellDifferentiation #LineageTracing
Trajectory analysis shows that STAMP’s resolution makes it a powerful tool for developmental biology and perturbation studies.
#DevelopmentalBiology #hESC
STAMP allows multi-sample profiling on a single slide, reducing batch effects and improving comparative analysis, particularly in drug response and perturbation studies.
#MultiSampleAnalysis #PerturbationScreening
STAMP represents a significant advance in single-cell research, offering scalable, multimodal RNA/protein profiling at low cost. Its versatility will support a broad range of research, from basic to clinical.
#SingleCellTechnology
Lots more coming soon...
@DrJasPlummer @hoheyn @pascual_reguant @EmanuelePitino1 @helucro @ximbaozao @irepan_salvador @Kellieiswise @m_mohenska @jc_nietos @cnag_eu @StJudeResearch @ACEpigenetics @M_ayco_N @eliseinsing Bill Flynn, Yutian Liu, Hannah Chasteen
Carly Whyte retweeted
Here we go…repurposing spatial imaging techs to achieve ultra-low to ultra-high, multiplexing, nuclei, cells, single (RNA or Protein), multimodal (RNA and Protein), super cheap! NO SEQUENCING!
@10xGenomics @nanostringtech @AkoyaBio @bruker
STAMP: Single-Cell Transcriptomics Analysis and Multimodal Profiling through Imaging | bioRxiv
@DrJasPlummer @hoheyn @pascual_reguant @eliseinsing @cnag_eu @ACEpigenetics @StJudeResearch biorxiv.org/content/10.1101/…
Carly Whyte retweeted
We are recruiting! Come join us in Adelaide to work on cutting-edge translational research and contribute to developing CAR-T cell therapies for brain tumours. Two post-doc positions available, closing soon, details at careers.pageuppeople.com/532…
Congrats to the team @LabListon @jldvib @olivertburton on this wonderful study 👏 #TissueTregs surprising us on every turn!
Biggest paper yet from the lab out now in @ImmunityCP! It is a massive #openscience resource on #tissueTregs, and what makes #Tregs tick in the #tissues. Spoiler-alert: Tissue Tregs are really different from what we all thought. 🧵 1/21
sciencedirect.com/science/ar…
Carly Whyte retweeted
So great to have this preprint out in the world. My first paper in this new field
I love, #StrepA.
Thanks to @JoshOsowicki and Andrew Steer @MCRI_for_kids for providing such a cool Strep A challenge model to study, & to all our coauthors, particularly @hrcfrost & @njmoreland
Excited to share this #StrepA human challenge preprint from a 🌟 team. @hrcfrost @DrDanikaHill @njmoreland @RHCMcG @AlanaWhitcombe @LicciardiLab @jcarapetis et al. Before/after serum IgG & saliva IgA for 19 #StrepA antigens & more 😊 biorxiv.org/content/10.1101/…
Carly Whyte retweeted
Very excited (& nervous) to share what we've been working on the past many years. Only took 3 first authors (Schreuder the experimentalist, @DawnSLin the analyst, and @syzmath the modeller) & co-senior Weber (computational, modeller, SynBio extraordinaire) biorxiv.org/content/10.1101/…
This represents how we believe haematopoiesis is actually proceeding at a clonal level. I'll walk through our preprint early next week. "A multi-track landscape of haematopoiesis informed by cellular barcoding and agent-based modelling" biorxiv.org/content/10.1101/…
Carly Whyte retweeted
Resource: A mega-thread of various #academic #career development projects I have worked on over the years.
First up, building career options into your PhD studies, written as part of #ImmunologyFutures for @ImmunolCellBiol with @lydiamakaroff
teapawt.net/LabListon/status/16791…
#PhD researchers - want to build your #career options for post-PhD? This strategic framework provides you the necessary goals and timelines to ensure you have a good range of career options after you graduate. 🧵1/4
@ImmunolCellBiol with @lydiamakaroff
onlinelibrary.wiley.com/doi/…
Carly Whyte retweeted
Flow/CyTOF users and leaders: here is an interface that allows you to see exactly where a given cell on a biaxial plot is on a corresponding UMAP. More details:
Carly Whyte retweeted
Seeking experienced senior molecular biologist to lead all single cell/spatial applications running in my lab.
Must be willing to learn new stuff all the time & teach students!
—>Postdoc Level A or B based on experience.
Email CV & Refs to [email protected]
Carly Whyte retweeted
Excited to be part of this massive international effort, leveraging the power of artificial intelligence in small molecule discovery. @CCB_Research @UniversitySA @AtomwiseInc nature.com/articles/s41598-0…
Carly Whyte retweeted
Immuno-PhD/Masters/Honours students, it can be hard to decide career direction. Register for our translational immunology conference (14-17 May, Melbourne) & hear from these huge companies! It could decide the next phase of your scientific career! apvic.org/
We hope this protocol will be a useful addition to your flow toolkit - better staining, less antibody, and shorter nights in the lab! We also provide some advice on fixatives, titration, buffer choice and optimising the perfect staining conditions 👌
For anyone doing #flowcytometry, would you like to have a new protocol that reduces your #antibody costs by ~10-fold and also gives you higher quality data, with better signal-to-noise ratio?
Yes? Then read work by @olivertburton and @CarlyEWhyte. 1/6
currentprotocols.onlinelibra…
Carly Whyte retweeted
Thank you to everyone who came to our publishing panel and specially our panelists @tahliajperry @kariisssaaa @CarlyEWhyte and Dr Cameron Bastow. We had an amazing turnout and an insightful discussion on getting your hard work published. Happy publishing everyone! 📖 📈🤩
Carly Whyte retweeted
Carly keeping our youngest ever Session Chair happy 👏
#AIR17 #immunology #AcademicTwitter @hosp_research @ASImmunology
Carly Whyte retweeted
This is absolutely wild - nature (as in mother) never ceases to amaze nature.com/articles/s41556-0…
Carly Whyte retweeted
Interested in tumour immunology? @Gotot_Lab @Unibonn and I are looking for 2 PhD students @BonnMelbPhD to work on Tregs in tumour. Students will spend their time between @UniBonn and @ONJCRI @UniMelbMDHS. Please RT @ASImmunology @dgfi_org @ImmunoSens
Carly Whyte retweeted
About 50-60% of advanced melanoma patients do not respond to immunotherapy. Why and what can we do about it? In this preprint we describe a prospective longitudinal clinical study we designed/conducted to address this (1/9). biorxiv.org/cgi/content/shor…
Carly Whyte retweeted
We've got positions open! #Postdoc #job in #neuroimmunology. Welcoming applicants from #neuroscience, #immunology, #molecularbiology. Come join an international, diverse, LGBT+ friendly team to work on an exciting @wellcometrust project!
babrahaminstitute.livevacanc…


























